Press Releases
Corporate News
7/28/2009
MLS COMPLETES EXPANSION OF cGMP FACILITY
5/19/2009
MLS Achieves Production Specification for the Australian Neonatal Rotavirus Vaccine
5/14/2009
MLS to Present at Bio 2009
1/23/2009
MLS Expands cGMP Facility
10/23/2008
MLS to manufacture rotavirus vaccine for MCRI and PATH
6/16/2008
MLS Completes Vybion Product Acquisition
5/13/2008
Meridian Signs Agreement to acquire Vybion Proteins
10/12/2007
USDA/APHIS EC 1774:2002 Approval For Its Viral Antigens Production Facility
8/28/2007
Commencement Of Phase I/II Clinical Trials Of Parvovirus B19 Vaccine
8/7/2007
Awarded NIH Contract For Production Of Experimental Vaccines
5/4/2007
COMMERCIAL AVAILABILITY OF A NOVEL RESPIRATORY SYNCYTIAL VIRUS CLINICAL CHALLENGE STOCK
3/20/2007
Meridian Bioscience Completes Restructuring and Expansion of Meridian Life Science Business
1/4/2007
Meridian Bioscience Completes Production of Clinical Respiratory Syncytial Virus
12/10/2003
VAI to Manufacture Parvovirus Vaccine for NIH - Overview Press Release
Product News
2/23/2010
MLS Introduces Lyophilized M-IgG
1/26/2010
MAb to Cryptococcus neoformans
12/18/2009
TRU Block Effectively Blocks RF
11/11/2009
MAbs to Adenovirus Type 40, 41, and Both
9/21/2009
Pandemic Influenza Strain Antibodies & Peptides
9/3/2009
Protein Products in Yeast
7/29/2009
Blocking Agents - Part 2
Swine Flu 2009 Update
5/11/2009
Blocking Agents Part 1
5/4/2009
Publication Cites use of MLS Toxoplasma gondii Antibody and Protein
4/14/2009
Researchers use MLS Purified Mouse Apo A1 as a standard
3/24/2009
High Performance Clones for Hormones
3/18/2009
Hormones and Steroids Product Line
3/10/2009
MLS Influenza Viruses Used to Test for Antibodies in Vaccine Delivery Study
2/25/2009
New MLS Infectious Disease Antigen Product Brochure
2/16/2009
TRU Block - Novel Active Blocker Released by MLS
1/26/2009
hCG Antigens and Antibodies
1/13/2009
Specification Sheets with Images
12/22/2008
Custom Antibody Production: In Vivo and In Vitro
12/11/2008
Publication Cites Use of HCV NS-5A and NS-4 MAbs
11/25/2008
Publication Cites MLS ApoB and A1AT Antibody use in HCV/VLDL Research
11/4/2008
FDA Publication Cites MLS Ab to Bioterrorism Agents
9/22/2008
TORCH Antigens
8/28/2008
Herpes Simplex Virus
8/6/2008
New Infectious Disease e-Catalog
7/26/2008
HBV and Apoptotic Caspase Activity
6/28/2008
Chicken Antibodies (Animal Immunoglobulins)
4/4/2008
Escherichia coli
3/13/2008
Hepatitis C
2/25/2008
MAb Production Brochure
2/6/2008
Bone/Calcium Metabolism
1/29/2008
Infectious Disease Focus (TB/HIV)
1/15/2008
Autoimmune Diseases